These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 217091

  • 21. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H, Blauhut B, Necek S, Kramar H, Vinazzer H.
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [Abstract] [Full Text] [Related]

  • 22. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 23. [Heparin cofactor II studies in thrombophilic patients].
    Pál A, Sas G.
    Orv Hetil; 1990 Mar 04; 131(9):461-2, 465. PubMed ID: 2179813
    [Abstract] [Full Text] [Related]

  • 24. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
    Thromb Haemost; 1993 Dec 20; 70(6):909-14. PubMed ID: 8165610
    [Abstract] [Full Text] [Related]

  • 25. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
    Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M.
    Blood Coagul Fibrinolysis; 1991 Jun 20; 2(3):435-9. PubMed ID: 1718466
    [Abstract] [Full Text] [Related]

  • 26. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency.
    Zucker ML, Gomperts ED, Marcus RG.
    S Afr Med J; 1976 Oct 09; 50(43):1743-8. PubMed ID: 63150
    [Abstract] [Full Text] [Related]

  • 27. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
    Carmignoto F, Schivo P, Plebani M, Pengo V, Piccini P, Ceriotti G.
    Quad Sclavo Diagn; 1981 Jun 09; 17(2):172-81. PubMed ID: 7267980
    [Abstract] [Full Text] [Related]

  • 28. Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran.
    Francis CW, Pellegrini VD, Stulberg BN, Miller ML, Totterman S, Marder VJ.
    J Bone Joint Surg Am; 1990 Aug 09; 72(7):976-82. PubMed ID: 1696577
    [Abstract] [Full Text] [Related]

  • 29. [Familial deficiency of antithrombin III].
    Coget JM, Dendien-Bernard S, Dupuis-Cuny C.
    Phlebologie; 1987 Aug 09; 40(2):381-91. PubMed ID: 3615614
    [Abstract] [Full Text] [Related]

  • 30. [Nephrotic syndrome, antithrombin III deficiency and recurrent thrombosis. The value of vitamin K antagonists].
    Guillot M, Fischer AM, Goldszmidt D, Bacri JL, Gagnadoux MF, Usberti M, Josso F, Broyer M.
    Arch Fr Pediatr; 1979 Nov 09; 36(9):930-3. PubMed ID: 555314
    [Abstract] [Full Text] [Related]

  • 31. [2 cases of recurrent deep venous thrombosis with protein C deficiency].
    Reinharez D.
    Phlebologie; 1985 Nov 09; 38(3):429-35. PubMed ID: 3840599
    [Abstract] [Full Text] [Related]

  • 32. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J, Veuillet-Duval A, Horellou MH, Samama M.
    Nouv Rev Fr Hematol (1978); 1982 Nov 09; 24(3):205-9. PubMed ID: 7133990
    [Abstract] [Full Text] [Related]

  • 33. [Clinical problems posed by the consumption of antithrombin III induced by heparin].
    Ferrer F, Augereau B, Angebault M, Vergoz D.
    Phlebologie; 1984 Nov 09; 37(1):77-81. PubMed ID: 6718507
    [Abstract] [Full Text] [Related]

  • 34. [Deep venous thrombosis and changes in antithrombin III in the postoperative period].
    Lasierra Cirujeda L, Martínez Celada M, Aza Pascual-Salcedo MJ, Hebrero San Martín J, Fernández Villamor A, Arévalo Manrique A.
    Sangre (Barc); 1985 Nov 09; 30(1):9-14. PubMed ID: 4002101
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of recurrent venous thrombosis: warfarin versus heparin.
    Miller WM, Medbery CA.
    N Engl J Med; 1980 Mar 27; 302(13):752. PubMed ID: 7354791
    [No Abstract] [Full Text] [Related]

  • 36. Antithrombin III deficiency in a Romanian family. Pathogenic role of concomitantly increased plasma level of clotting factors VII and X.
    Cucuianu M, Comes L, Roman S, Boeru A.
    Med Interne; 1984 Mar 27; 22(1):13-7. PubMed ID: 6710043
    [Abstract] [Full Text] [Related]

  • 37. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
    Carmassi F, Morale M, De Negri F, Carrai M.
    J Mol Med (Berl); 1995 Feb 27; 73(2):89-93. PubMed ID: 7627635
    [Abstract] [Full Text] [Related]

  • 38. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P, Lewandowski K, Turowiecka Z, Zozulińska M, Tokarz A, Zawilska K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Feb 27; 117(2):229-36. PubMed ID: 1697824
    [Abstract] [Full Text] [Related]

  • 39. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
    Bordigoni P, Briquel E, Olive D.
    Arch Fr Pediatr; 1981 Nov 27; 38(9):653-5. PubMed ID: 6949499
    [Abstract] [Full Text] [Related]

  • 40. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P, Rolović Z, Elezović I, Antunović P, Stanojević M, Colović M.
    Srp Arh Celok Lek; 1999 Nov 27; 127(1-2):21-7. PubMed ID: 10377836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.